These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7329802)

  • 21. [Study in vitro concerning the mechanism of the neutralization of heparin by its antagonists].
    Páusesco E; Trandafiresco E
    Hemostase; 1966; 6(1):25-39. PubMed ID: 5911784
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of a high molecular weight heparin binding acidic growth factor in human placenta.
    Triantos A; Koliakos G; Kavoukopoulos E; Dimitriadou A; Trakatellis A
    Biochem Mol Biol Int; 1995 Nov; 37(4):737-45. PubMed ID: 8589647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
    Becker RC; Alexander J; Li YF; Bovill E; Spencer FA; Robertson TL; Kunitada S; Dyke CK; Harrington RA
    Thromb Haemost; 2004 Dec; 92(6):1229-31. PubMed ID: 15622616
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interaction of antitubercular preparations with heparin].
    Nikolaev VP
    Probl Tuberk; 1984 Oct; (10):62-4. PubMed ID: 6514702
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction of heparan sulfate and its fractions with endothelial cells in culture.
    Tiozzo R; Cingi MR; Croce MA
    Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hydrolysis of heparin by the immobilized enzymatic complex from Streptomyces kurssanovii].
    Bannikova GE; Stolbushkina PP; Drozd NN; Vikhoreva GA; Varlamov VP; Makarov VA; Panov AV
    Prikl Biokhim Mikrobiol; 2004; 40(4):429-34. PubMed ID: 15455715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocan is a heparin binding proteoglycan.
    Feng K; Arnold-Ammer I; Rauch U
    Biochem Biophys Res Commun; 2000 Jun; 272(2):449-55. PubMed ID: 10833434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
    Abzalimov RR; Dubin PL; Kaltashov IA
    Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problems of high molecular chemistry].
    Vestn Akad Nauk SSSR; 1968 Apr; 38(4):19-23. PubMed ID: 5738570
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biological activities of heparins, other than their antithrombotic action].
    Vairel EG
    Ann Pharm Fr; 1994; 52(2):81-8. PubMed ID: 7944183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of various forms of heparin on the release of immune complexes from the surface of cultured mesangial cells.
    Drakeley SJ; Furness PN
    J Pathol; 1996 Apr; 178(4):458-61. PubMed ID: 8691327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reaction between heparin and fibrin monomer and fibrin monomer--fibrinogen complexes].
    Kudriashov BA; Liapina LA; Grigorova EA
    Vopr Med Khim; 1980; 26(3):318-21. PubMed ID: 7456362
    [No Abstract]   [Full Text] [Related]  

  • 33. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
    Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
    Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi heparin-binding proteins and the nature of the host cell heparan sulfate-binding domain.
    Oliveira FO; Alves CR; Calvet CM; Toma L; Bouças RI; Nader HB; Castro Côrtes LM; Krieger MA; Meirelles Mde N; Souza Pereira MC
    Microb Pathog; 2008 Apr; 44(4):329-38. PubMed ID: 18037261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
    Castor CW; Kotlyar A; Edwards BE
    J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcium ions on the scattering of light by heparin.
    Loucas SP; Yeh KC; Haddad HM
    J Pharm Sci; 1971 Jul; 60(7):1109-10. PubMed ID: 5115261
    [No Abstract]   [Full Text] [Related]  

  • 37. Sustained release of human growth hormone from heparin-based hydrogel.
    Choi WI; Kim M; Tae G; Kim YH
    Biomacromolecules; 2008 Jun; 9(6):1698-704. PubMed ID: 18457449
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of heparin and low molecular weight heparins on platelets.
    Vermylen JG
    Semin Thromb Hemost; 1993; 19 Suppl 1():20-1. PubMed ID: 8395723
    [No Abstract]   [Full Text] [Related]  

  • 39. Low molecular weight heparin.
    Hirsh J
    Thromb Haemost; 1993 Jul; 70(1):204-7. PubMed ID: 8236105
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of keratinocyte growth factor binding to heparin and dextran sulfate.
    Wen J; Hsu E; Kenney WC; Philo JS; Morris CF; Arakawa T
    Arch Biochem Biophys; 1996 Aug; 332(1):41-6. PubMed ID: 8806707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.